# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001178913-22-002842
Filing Date
2022-08-01
Accepted
2022-08-01 06:30:40
Documents
48
Period of Report
2022-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8k.htm iXBRL | 8-K | 35652
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 75445
7 |  | exhibit_99-1slide1.jpg | GRAPHIC | 67904
8 |  | exhibit_99-1slide2.jpg | GRAPHIC | 335239
9 |  | exhibit_99-1slide3.jpg | GRAPHIC | 273915
10 |  | exhibit_99-1slide4.jpg | GRAPHIC | 159425
11 |  | exhibit_99-1slide5.jpg | GRAPHIC | 201618
12 |  | exhibit_99-1slide6.jpg | GRAPHIC | 169862
13 |  | exhibit_99-1slide7.jpg | GRAPHIC | 148577
14 |  | exhibit_99-1slide8.jpg | GRAPHIC | 75128
15 |  | exhibit_99-1slide9.jpg | GRAPHIC | 245267
16 |  | exhibit_99-1slide10.jpg | GRAPHIC | 181258
17 |  | exhibit_99-1slide11.jpg | GRAPHIC | 162632
18 |  | exhibit_99-1slide12.jpg | GRAPHIC | 184510
19 |  | exhibit_99-1slide13.jpg | GRAPHIC | 157106
20 |  | exhibit_99-1slide14.jpg | GRAPHIC | 192414
21 |  | exhibit_99-1slide15.jpg | GRAPHIC | 87030
22 |  | exhibit_99-1slide16.jpg | GRAPHIC | 176529
23 |  | exhibit_99-1slide17.jpg | GRAPHIC | 158496
24 |  | exhibit_99-1slide18.jpg | GRAPHIC | 181292
25 |  | exhibit_99-1slide19.jpg | GRAPHIC | 161240
26 |  | exhibit_99-1slide20.jpg | GRAPHIC | 153904
27 |  | exhibit_99-1slide21.jpg | GRAPHIC | 178751
28 |  | exhibit_99-1slide22.jpg | GRAPHIC | 232152
29 |  | exhibit_99-1slide23.jpg | GRAPHIC | 216567
30 |  | exhibit_99-1slide24.jpg | GRAPHIC | 185157
31 |  | exhibit_99-1slide25.jpg | GRAPHIC | 66284
32 |  | exhibit_99-1slide26.jpg | GRAPHIC | 240379
33 |  | exhibit_99-1slide27.jpg | GRAPHIC | 242124
34 |  | exhibit_99-1slide28.jpg | GRAPHIC | 160319
35 |  | exhibit_99-1slide29.jpg | GRAPHIC | 111506
36 |  | exhibit_99-1slide30.jpg | GRAPHIC | 74437
37 |  | exhibit_99-1slide31.jpg | GRAPHIC | 52167
38 |  | exhibit_99-1slide32.jpg | GRAPHIC | 223329
39 |  | exhibit_99-1slide33.jpg | GRAPHIC | 207588
40 |  | exhibit_99-1slide34.jpg | GRAPHIC | 137490
| Complete submission text file | 0001178913-22-002842.txt |  | 8311691

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | entx-20220801.xsd | EX-101.SCH | 4734
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | entx-20220801_def.xml | EX-101.DEF | 18406
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | entx-20220801_lab.xml | EX-101.LAB | 28719
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | entx-20220801_pre.xml | EX-101.PRE | 20642
42 | EXTRACTED XBRL INSTANCE DOCUMENT | form8k_htm.xml | XML | 6885

Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 221122692
SIC: 2836 Biological Products, (No Diagnostic Substances)